Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-25 @ 3:47 AM
NCT ID:
NCT04942002
Eligibility Criteria:
Inclusion Criteria:
* Both genres
* Age between 18 and 85 years old.
* Optic neuritis diagnosis ( relative afferent pupillary defect, acquired dyschromatopsia, low vision, prechiasmatic campimetric defect)
* 1 month after symptoms started
* If is a bilateral simultaneous optic neuritis the eye with the worst vision will be included.
* if is a bilateral sequential optic neuritis the eye with lees 1 month evolution will be included.
Exclusion Criteria:
* Visual field better than 20/60 at the beginning of the study.
* History of optic neuritis in the eye under study.
* History of additional ophthalmological or neurological pathology that has caused visual loss in the eye under study.
* History of previous treatment with intravenous methylprednisolone since the onset of symptoms.
* History of high myopia.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT04942002
Study Brief:
Protocol Section:
NCT04942002